Ignite Creation Date:
2024-05-06 @ 10:26 AM
Last Modification Date:
2024-10-26 @ 12:30 PM
Study NCT ID:
NCT03256136
Status:
COMPLETED
Last Update Posted:
2020-11-04
First Post:
2017-08-17
Brief Title:
Nivolumab in Combination With Chemotherapy or Nivolumab in Combination With Ipilimumab in Advanced EGFR-Mutant or ALK-Rearranged NSCLC
Sponsor:
Massachusetts General Hospital
Organization:
Massachusetts General Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-22
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08-19
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-17
First Submit QC Date:
August 17 2017
Study First Post Date:
2017-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-10-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-14
Last Update Post Date:
2020-11-04
Last Update Post Date Type:
ACTUAL